Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Phase II study of talazoparib in advanced cancers with BRCA1/2, DNA repair, and PTEN alterations ; volume:8 ; number:1 ; day:31 ; month:7 ; year:2024 ; pages:1-14 ; date:12.2024
npj precision oncology ; 8, Heft 1 (31.7.2024), 1-14, 12.2024
- Urheber
-
Piha-Paul, Sarina A.
Tseng, Chieh
Leung, Cheuk Hong
Yuan, Ying
Karp, Daniel D.
Subbiah, Vivek
Hong, David
Fu, Siqing
Naing, Aung
Rodon, Jordi
Javle, Milind
Ajani, Jaffer A.
Raghav, Kanwal P.
Somaiah, Neeta
Mills, Gordon B.
Tsimberidou, Apostolia M.
Zheng, Xiaofeng
Chen, Ken
Meric-Bernstam, Funda
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-024-00634-6
- URN
-
urn:nbn:de:101:1-2410250843479.833437116246
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Piha-Paul, Sarina A.
- Tseng, Chieh
- Leung, Cheuk Hong
- Yuan, Ying
- Karp, Daniel D.
- Subbiah, Vivek
- Hong, David
- Fu, Siqing
- Naing, Aung
- Rodon, Jordi
- Javle, Milind
- Ajani, Jaffer A.
- Raghav, Kanwal P.
- Somaiah, Neeta
- Mills, Gordon B.
- Tsimberidou, Apostolia M.
- Zheng, Xiaofeng
- Chen, Ken
- Meric-Bernstam, Funda
- SpringerLink (Online service)
Ähnliche Objekte (12)
PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
Prevalence of APC and PTEN Alterations in Urachal Cancer
Prevalence of APC and PTEN Alterations in Urachal Cancer
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
PTEN loss correlates with T cell exclusion across human cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Genomic alterations in oral multiple primary cancers
SWI/SNF Alterations in Squamous Bladder Cancers
The dysregulation of BRCA1, PTEN, or CHK1 influences therapy resistance of breast cancer cells by affecting DNA repair and DNA replication stress signaling
PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
Prevalence of APC and PTEN Alterations in Urachal Cancer
Prevalence of APC and PTEN Alterations in Urachal Cancer
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
PTEN loss correlates with T cell exclusion across human cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Genomic alterations in oral multiple primary cancers
SWI/SNF Alterations in Squamous Bladder Cancers
The dysregulation of BRCA1, PTEN, or CHK1 influences therapy resistance of breast cancer cells by affecting DNA repair and DNA replication stress signaling
PARG deficiency is neither synthetic lethal with BRCA1 nor PTEN deficiency
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
Prevalence of APC and PTEN Alterations in Urachal Cancer
Prevalence of APC and PTEN Alterations in Urachal Cancer
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
The BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers
PTEN loss correlates with T cell exclusion across human cancers
PIK3CA alterations in Middle Eastern ovarian cancers
Genomic alterations in oral multiple primary cancers
SWI/SNF Alterations in Squamous Bladder Cancers